BIOMAT Database Logo BIOMAT Database Logo

[The effect of anticoagulant therapy on the dynamics of electrocardiographic indices in patients with myocardial infarct]. 1968

V D Churin

UI MeSH Term Description Entries
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

V D Churin
[Effect of desensitization therapy on clinical-laboratory indices in patients with myocardial infarct].
March 1971, Terapevticheskii arkhiv,
V D Churin
[ON EXPERIENCES WITH ANTICOAGULANT THERAPY IN MYOCARDIAL INFARCT].
January 1964, Das Deutsche Gesundheitswesen,
V D Churin
[Dynamic characteristics of the electrocardiographic and biochemical indices in myocardial infarct patients undergoing thrombolytic therapy].
January 1987, Terapevticheskii arkhiv,
V D Churin
[Effect of anticoagulant therapy on blood coagulation and fibrinolysis in patients with acute myocardial infarct].
September 1974, Vrachebnoe delo,
V D Churin
[Effect of anticoagulant therapy on scar formation following myocardial infarct].
January 1959, Thrombosis et diathesis haemorrhagica,
V D Churin
[Anticoagulant therapy in myocardial infarct].
October 1952, La Presse medicale,
V D Churin
[Anticoagulant therapy in myocardial infarct].
August 1965, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
V D Churin
[Anticoagulant therapy in myocardial infarct].
April 1965, Lakartidningen,
V D Churin
[ONCE AGAIN ON THE ANTICOAGULANT THERAPY REGIMEN FOR PATIENTS WITH MYOCARDIAL INFARCT].
March 1965, Terapevticheskii arkhiv,
V D Churin
[Effect of low doses of cardiac glycosides on electrocardiographic indices following physical load in myocardial infarct patients].
February 1975, Vrachebnoe delo,
Copied contents to your clipboard!